Heartworm Disease Market Report Overview
Heartworm disease is commonly present in pets like cats and dogs, which may be lethal in extreme circumstances. Heartworms are transmitted by bites of mosquitoes that bear larvae of the infectious heartworm. The larvae reaches in heart and lungs of dogs and begin to develop in these organs. Species such as coyotes and foxes remain near to certain populated centers and are also thought to be major carriers of heartworm disease. For heartworms, dogs are known to be a natural host. A slight recurring cough, exhaustion after moderate activity, inability to exercise, weight loss, and reduced appetite are the signs of heartworm disease. Three injections are commonly used to treat dogs, namely, melarsomine, doxycycline, and prednisone. The injection of melarsomine kills adult heartworms and decreases chances of unintended side effects. In addition, surgery to extract worms from heart and arteries inside lungs is needed for a serious case of heartworm disease.
COVID-19 scenario analysis:
COVID-19 outbreak has led to slowdown in the global economic growth. Rise in number of COVID-19 cases and related deaths across the globe has impacted most industries and markets in both negative and positive ways. The world economy is influenced by COVID-19 in three major ways: by actively impacting production and demand, by developing a supply chain and industry disruption, and by its financial effect on businesses and financial markets. COVID-19 has also impacted the heartworm disease market in a positive way as during this pandemic many COVID-19 positive patient treated with mostly with Hydrochloroquine but the patients with mild and minor symptoms are treated with ivermectin, which is also known as slow killer drug used to kill heartworms. Hence, increase in COVID-19 patients has led to rise in the demand for the drug, which propels the heartworm disease market growth.
Top impacting factors: Market Scenario Analysis, Trends, Drivers, and Impact Analysis:
Rise in awareness regarding animal welfare and increase in incidences of fatal diseases in pets propels the market growth. Moreover, rise in understanding of veterinary healthcare along with implementation of strict regulations to deter animal diseases also boosts growth of the market. Furthermore, heartworm medicines come in multiple ways that are only available by prescription from veterinarians. This has contributed to rise in pet health insurance demand, which in turn, is expected to fuel growth of the market for heartworm care. However, while rise in spending on healthcare suggests a positive outlook for the market for heartworm treatment, high costs associated with preventive measures may impede growth of the market for heartworm treatment.
Surge in number of mergers and acquisitions to propel the market :
Rise in number of mergers and acquisitions is anticipated to help the industry boost in the coming years. For instance, in January 2019, Merial, a part of Boehringer Ingelheim, introduced Heartworm 2020, an initiative dedicated for heartworm disease prevention in dogs. The initiative provided heartworm disease education tools and incentives to pet owners, via veterinarians, thereby helping in the heartworm disease market growth.
Key benefits of the report:
- This report provides a detailed quantitative analysis of the heartworm disease market trends and its forecast estimations, which assists to identify prevailing opportunities in the heartworm disease market.
- A deep analysis various region to provide exact insights by which a company or industry plans their next moves.
- The projections in this report are made by analyzing current heartworm disease market and future market potential, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
Questions answered in the heartworm disease market research report:
- Which are the leading market players active in the heartworm disease market?
- What would be the detailed impact of COVID-19 on the market?
- What current trends would influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the heartworm disease market?
- What are the projections for the future that would help in taking further strategic steps?
Heartworm Disease Market Report Highlights
| Aspects | Details |
 By Animal Type |
|
 By Product Type |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Pfizer Inc, Boehringer Ingelheim, Mylan N.V, HEARTGARD Plus, Merck Animal Health (Merck & Co., Inc.), Ecto Development Corporation, PetCareRx, Wellmark International, Inc, Bayer AG, Ceva Sante Animale S.A |
 Other Players | AdvaCare Pharma, Eli Lilly and Company, Elanco, Merial Animal Health Ltd, Bristol-Meyers Squibb Co, Zoetis Services LLC. |
Loading Table Of Content...
